Biotech Stocks: Geron rallies on FDA move; Merck slides
Source: MarketWatch
Friday 30th July, 2010
BOSTON (MarketWatch) -- Geron Corp. shares rallied early Friday on news that the U.S. Food and Drug Administration is allowing the company to proceed with the world's first clinical study to test an e... ...
Read the full story at
MarketWatch
Email this story to a friend
Have your say on this story